A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT07211542 · RECRUITING
Trial details
- NCT number
- NCT07211542
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.